KCAS Bio
↗Olathe, Kansas, USA
KCAS Bio is a global, full-service contract research organization (CRO) specializing in bioanalytical and biomarker services. The company supports the pharmaceutical and biotechnology industries across the entire drug development lifecycle, from early discovery and preclinical research through clinical development and commercialization.
KCAS Bio provides comprehensive analytical solutions including small and large molecule bioanalysis, immunogenicity testing, flow cytometry, and molecular biology. With facilities in the United States (Kansas and Pennsylvania) and France, and a strategic alliance in Australia, the company is recognized for its regulatory compliance (GLP/GCP) and has contributed to over 315 drug approvals.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:1979
Ownership:private
Status:operating
FUNDING
Total Raised:$0
Investors:Vitruvian Partners
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Crux Biolabs (Strategic alliance in Australia), Sciex (Collaboration on bioanalytical technology)
COMPETITION
Position:Leader
Competitors:BioAgilytix, NorthEast BioLab, BioPharma
LEADERSHIP
Key Executives:
John Bucksath - CEO
Board Members:Paul Kirchgraber, Kurt Doyle
LINKS
Website:kcasbio.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of KCAS Bio and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with KCAS Bio. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.